SMTL ID : 6ts7.1

Coagulation factor XI protease domain in complex with active site inhibitor

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.63 Å

Oligo State

monomer

Ligands

1 x NWE: 2-[2-[[3-(1,2,3,4-tetrahydroisoquinolin-7-yl)phenyl]methoxy]phenyl]ethanoic acid(Non-covalent)

NWE.1: 15 residues within 4Å: Chain A: C.29, H.44, D.182, A.183, C.184, K.185, G.186, D.187, S.188, T.206, W.208, G.209, G.211, C.212, G.219 10 PLIP interactions: 10 interactions with chain A Hydrophobic interactions: A:A.183, A:K.185, A:K.185 Hydrogen bonds: A:D.182, A:G.186, A:D.187, A:S.188, A:S.188 Salt bridges: A:H.44 pi-Stacking: A:H.44

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Lorthiois, E. et al., Structure-Based Design and Preclinical Characterization of Selective and Orally Bioavailable Factor XIa Inhibitors: Demonstrating the Power of an Integrated S1 Protease Family Approach. J.Med.Chem. (2020)

Release Date

2020-07-08

Peptides

Coagulation factor XI: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Coagulation factor XI

Related Entries With Identical Sequence